Instead GAD-Abs may be secondary to irreversible T cell-mediated or other damage leading to release of intracellular GAD, perhaps occurring in patients with or at high risk of autoimmunity, leading to autoantibody generation [22–24]. The gene discussed is DDX41; the disease is Autoimmunity.